Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma
Open Access
- 27 March 2007
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 120 (11), 2418-2425
- https://doi.org/10.1002/ijc.22551
Abstract
Dendritic cells (DC) are potent antigen‐presenting cells that can present tumor antigens chaperoned by heat shock proteins (HSPs), while local hyperthermia (LHT) can increase the expression of HSPs. In this study, we determine if intratumoral injection of immature DC after LHT (LHT+IT‐DC) induces systemic antitumor immunity in patients with advanced melanoma, and investigate the potential immunological mechanisms involved in the treatments. Patients were randomly assigned to intratumoral administration of autologous immature DC triweekly, with (LHT+IT‐DC, arm A, n = 9) or without (IT‐DC, arm B, n = 9) LHT. Our results showed that there were no grade 3/4 toxicities. The time to progress (TTP) of arm A was 5 months, significantly longer than that in arm B (2 months, p < 0.05). However, the overall survival time had no statistical difference (13 months vs. 6 months, p > 0.05) between the 2 groups. Our ELISPOT assay showed a significantly increased melanoma‐specific IFN‐γ production in arm A, suggesting that LHT+IT‐DC was more effective in the induction of cytotoxic T lymphocytes (CTL) than IT‐DC alone. Furthermore, we detected an increased HSPs expression 4 hr after the first LHT, an enhanced Th1/Th2 chemokines production 24 hr after the first LHT+IT‐DC treatment, a promoted migration of DC to afferent lymph nodes, and a decreased infiltration of regulatory T cells (CD4+CD25+) and an increased infiltration of active CTL (CD8+CD28+) 48 hr after the third DC injection in arm A patients. Therefore, LHT+IT‐DC can induce effective specific antitumor immunity and facilitate a Th1‐polarized immune response in patients with advanced melanoma.Keywords
This publication has 53 references indexed in Scilit:
- Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticlesInternational Journal of Cancer, 2005
- Dendritic cells delivered inside human carcinomas are sequestered by interleukin‐8International Journal of Cancer, 2005
- Intratumoral Injection of Dendritic Cells Engineered to Secrete Interleukin-12 by Recombinant Adenovirus in Patients With Metastatic Gastrointestinal CarcinomasJournal of Clinical Oncology, 2005
- Immunologic escape and angiogenesis in human malignant melanomaJournal of the American Academy of Dermatology, 2003
- Influence of drug‐induced apoptotic death on processing and presentation of tumor antigens by dendritic cellsInternational Journal of Cancer, 2003
- Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte ResponsesThe Journal of Experimental Medicine, 2001
- Reversal of TNF-α resistance by hyperthermia: Role of mitochondriaLife Sciences, 2000
- Apoptosis induced by hyperthermia in Dunn osteosarcoma cell line in vitroInternational Journal of Hyperthermia, 2000
- Editorial CommentInternational Journal of Hyperthermia, 1997
- Hyperthermia, chemotherapeutic agents and oncogenic transformationInternational Journal of Hyperthermia, 1986